World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
47014
World Ranking
8165
National Ranking
4235

Overview

Russell Broaddus is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans multiple fields within medicine and the biomedical sciences, with a strong focus on cancer research and related molecular mechanisms.

The primary fields of study for Broaddus include Medicine and Biochemistry, Genetics, and Molecular Biology. Their work delves into several subfields such as Molecular Biology, Cancer Research, Obstetrics and Gynecology, Pathology and Forensic Medicine, and Oncology.

Broaddus has contributed extensively to topics including Endometrial and Cervical Cancer Treatments, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, Ovarian cancer diagnosis and treatment, Cancer-related gene regulation, and Cervical Cancer and HPV Research.

Frequent coauthors in Broaddus's research efforts include Andrew B. Gladden, Karen H. Lu, Bryan Fellman, Victoria Bae-Jump, and Melinda S. Yates.

Prominent publication venues for Broaddus include Clinical Cancer Research, Gynecologic Oncology, International Journal of Gynecological Cancer, UNC Libraries, and bioRxiv (Cold Spring Harbor Laboratory).

Representative recent papers by Broaddus include:

  • Endometrial Cancer, 2020, New England Journal of Medicine
  • Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer, 2022, Archives of Pathology & Laboratory Medicine
  • Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer, 2020, American Journal of Obstetrics and Gynecology
  • Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer, 2020, Cancer Cell
  • Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline, 2023, Journal of Clinical Oncology

Best Publications

  • Integrated genomic characterization of endometrial carcinoma

    Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Regulation of inflammatory responses by IL-17F.

    Xuexian O. Yang;Seon Hee Chang;Heon Park;Roza Nurieva

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

    Victor Abkevich;Kirsten Timms;Bryan T. Hennessy;Jennifer Potter

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability

    Lydia W.T. Cheung;Bryan T. Hennessy;Bryan T. Hennessy;Jie Li;Shuangxing Yu

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

    Da Yang;Yan Sun;Yan Sun;Limei Hu;Hong Zheng;Hong Zheng

  • Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

    Karen H. Lu;Mai Dinh;Wendy Kohlmann;Patrice Watson

  • Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

    Funda Meric-Bernstam;Lauren Brusco;Kenna Shaw;Chacha Horombe

  • Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

    Bryan T.J. Hennessy;Kirsten M. Timms;Mark S. Carey;Alexander Gutin

  • Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

    Brian M Slomovitz;Thomas W Burke;Patricia J Eifel;Lois M Ramondetta

  • Integrated Molecular Characterization of Uterine Carcinosarcoma

    Andrew D. Cherniack;Hui Shen;Vonn Walter;Chip Stewart

  • Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

    Rebecca T. Marquez;Keith A. Baggerly;Andrea P. Patterson;Jinsong Liu

  • Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.

    Karen H. Lu;John O. Schorge;Kerry J. Rodabaugh;Molly S. Daniels

  • Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.

    Russell R. Broaddus M.D.;Henry T. Lynch;Lee-may Chen;Molly S. Daniels

  • Integrated analyses identify a master microrna regulatory network for the mesenchymal subtype in serous ovarian cancer [Cancer Cell 23 (2013) 186-199]

    Da Yang;Yan Sun;Limei Hu;Hong Zheng

Frequent Co-Authors

Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Rajyalakshmi Luthra
Rajyalakshmi Luthra The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Scott Kopetz
Scott Kopetz The University of Texas MD Anderson Cancer Center
David M. Gershenson
David M. Gershenson The University of Texas MD Anderson Cancer Center
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in healthcare offers flexible options for those looking to advance or start their careers in medicine. Many nurses choose bridge programs to build on existing credentials. For example, those seeking to earn a Bachelor of Science in Nursing can consider options like an rn to bsn with no clinicals program, which allows RNs to advance without on-site training requirements.

If you already have a master’s in nursing, you may be interested in accelerated msn to dnp programs. These streamlined online programs help experienced nurses achieve a Doctor of Nursing Practice degree faster. Cost is also a key consideration; those seeking affordability can explore the cheapest online dnp programs to complete their studies with less financial strain.

For prospective nurses aiming to enter the workforce quickly, it's important to know what is the fastest way to become an lpn. Fast-track LPN programs online can provide a direct route to licensure and employment, making them an increasingly popular choice in today’s healthcare landscape.

Best Scientists Citing Russell Broaddus

Trending Scientists